23448 (LAB.TO) (LAB) Scheduled to Post Quarterly Earnings on Thursday

23448 (LAB.TO) (TSE:LAB) is scheduled to be releasing its earnings data before the market opens on Thursday, November 14th.

23448 (LAB.TO) (TSE:LAB) last posted its quarterly earnings results on Wednesday, August 14th. The company reported C($0.01) EPS for the quarter, hitting the consensus estimate of C($0.01). The business had revenue of C$11.14 million for the quarter, compared to analysts’ expectations of C$10.26 million.

23448 (LAB.TO) Stock Performance

About 23448 (LAB.TO)

Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies.